Latest posts by Lawrence F Muscarella PhD (see all)
- Wrongful Death Suit Blames a Chicago-Area Hospital and Endoscope Manufacturer for a Fatal ‘Superbug’ Infection - September 2, 2015
- A ‘Trickle-Down Effect’: The Potential Impact of the FDA’s Warning About Endoscope Safety on Automated Endoscope Reprocessors - August 21, 2015
- Another Potentially Deadly ‘Superbug’ Outbreak Suspected at a Pasadena Hospital - August 21, 2015
This article discusses the evolution of the labeling of a medical device — namely, of the “Instructions for Use” of Cidex OPA, which is used to high-level disinfection semi-critical devices, including gastrointestinal endoscopes.
For the reader’s convenience, this article is divided into 3 parts. The first and second parts are featured below.
The third part of this discussion, which provides guidance for the save and proper use of Cidex OPA, is provided in another of Dr. Muscarella’s article entitled “Recommendations for the Safe and Effective Use of ortho-phthalaldehyde“: click here to read it.